|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Dry Eye Syndrome | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Blepharitis | |||||
| Dry Eye Syndromes | |||||
| Eye Diseases | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Disease | |||||
| Eyelid Diseases | |||||
| Lacrimal Apparatus Diseases | |||||
| Pathologic Processes | |||||
| 4 | Interventions listed in this trial | ||||
| Tetracycline: Doxycycline analog | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Doxycycline | |||||
| Tetracycline | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anti-Bacterial Agents | |||||
| Anti-Infective Agents | |||||
| Antimalarials | |||||
| Antiparasitic Agents | |||||
| Antiprotozoal Agents | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Protein Synthesis Inhibitors | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| University of Texas Southwestern Medical Center | |||||